Boden G, Tappy L
Department of Medicine, Temple University School of Medicine, Philadelphia, PA.
Diabetes. 1990 Sep;39(9):1079-84. doi: 10.2337/diab.39.9.1079.
Free fatty acids are known to inhibit carbohydrate disposal and oxidation. This action may play an important role in the pathophysiology of insulin resistance and non-insulin-dependent diabetes mellitus. To investigate whether amino acids (AAs) have similar actions, we determined the effects of an intravenously infused mixture of 15 AAs on carbohydrate disposal during euglycemic-hyperinsulinemic clamps associated with either basal or high glucagon concentrations in healthy male volunteers. Plasma glucose concentration was clamped at approximately 4.7 mM (coefficient of variation 4.7%). Insulin infusion (7.18 pmol.kg-1.min-1) raised serum insulin concentrations from 36-50 pM to between 300 and 600 pM. AA infusions (0.5 g.kg-1.h-1.4 h) raised plasma alpha-amino N2 concentrations about five- to six-fold. Infusion of AAs, somatostatin (somatotropin release inhibitory factor, SRIF), and high-glucagon replacement (3.0 ng.kg-1.min-1) reduced the rate of exogenous glucose infusion needed to maintain euglycemia from 51.1 +/- 7.2 mumol.kg-1.min-1 (saline + SRIF + high glucagon) to 28.3 +/- 11.1 mumol.kg-1.min-1 and stimulated endogenous glucose production (from 0 to approximately 17 mumol.kg-1.min-1). Thus, glucose disposal (exogenous infusion plus endogenous production of glucose) remained essentially unchanged. During infusion of AAs + SRIF + basal glucagon replacement (0.25 ng.kg-1.min-1), endogenous glucose production remained completely suppressed, and the rates of exogenous glucose infusion did not change (compared with saline + SRIF + basal glucagon replacement). The data showed that 1) hyperaminoacidemia associated with hyperglucagonemia stimulated endogenous glucose production despite hyperinsulinemia, and 2) intravenous infusion of a mixture of 15 AAs had no inhibitory effect on insulin-stimulated total-body glucose disposal.
已知游离脂肪酸会抑制碳水化合物的代谢及氧化。这一作用可能在胰岛素抵抗和非胰岛素依赖型糖尿病的病理生理过程中发挥重要作用。为研究氨基酸(AAs)是否有类似作用,我们在健康男性志愿者处于正常血糖 - 高胰岛素钳夹状态且伴有基础或高胰高血糖素浓度时,测定了静脉输注15种氨基酸混合物对碳水化合物代谢的影响。血浆葡萄糖浓度被钳定在约4.7 mM(变异系数4.7%)。胰岛素输注(7.18 pmol·kg⁻¹·min⁻¹)使血清胰岛素浓度从36 - 50 pM升至300至600 pM之间。氨基酸输注(0.5 g·kg⁻¹·h⁻¹,共1.4小时)使血浆α - 氨基N₂浓度升高约五至六倍。输注氨基酸、生长抑素(促生长激素释放抑制因子,SRIF)以及补充高剂量胰高血糖素(3.0 ng·kg⁻¹·min⁻¹),将维持正常血糖所需的外源性葡萄糖输注速率从51.1±7.2 μmol·kg⁻¹·min⁻¹(生理盐水 + SRIF + 高剂量胰高血糖素)降至28.3±11.1 μmol·kg⁻¹·min⁻¹,并刺激内源性葡萄糖生成(从0增至约17 μmol·kg⁻¹·min⁻¹)。因此,葡萄糖代谢(外源性输注加内源性葡萄糖生成)基本保持不变。在输注氨基酸 + SRIF + 基础剂量胰高血糖素替代物(0.25 ng·kg⁻¹·min⁻¹)期间,内源性葡萄糖生成仍被完全抑制,且外源性葡萄糖输注速率未改变(与生理盐水 + SRIF + 基础剂量胰高血糖素替代物相比)。数据表明:1)与高胰高血糖素血症相关的高氨基酸血症尽管存在高胰岛素血症仍刺激内源性葡萄糖生成;2)静脉输注15种氨基酸混合物对胰岛素刺激的全身葡萄糖代谢无抑制作用。